Novel Oral Poliomyelitis Vaccine Type 2 (nOPV2)
Poliomyelitis vaccines (novel, oral, live, attenuated, type 2)
Product Details
WHO Product ID
FVP-P-404
Status
Acceptable
Date of prequalification
Vaccine type
Poliomyelitis vaccines (novel, oral, live, attenuated, type 2)
Abbreviated Name
nOPV2
Commercial Name
Novel Oral Poliomyelitis Vaccine Type 2 (nOPV2)
PQ Holder
Indonesia
NRA of record
National Agency of Drug and Food Control Indonesia (NADFCI)
Product description
Pharmaceutical Form
Liquid: Ready to use
Presentation
Vial
Number of doses
50
Route of administration
Oral
Vaccine Vial Monitor
Type 2
Shelf-life
24
Storage temperature
-20°C
Diluent
N/A
Preservative
None
Multidose Vial Policy
WHO recommends that opened vials of this vaccine may be used in subsequent immunization sessions (up to 28 days) if the conditions outlined in the WHO Policy Statement are met.
Product Packaging
Secondary Container
Shipping Container
Component Packed
Active (Vaccine)
Total doses
10
Dimensions
11.5 x 5.1 x 4.7 cm
Cold Chain Volume (cm³/dose)
0.55